23/10/2009 (Agence Europe) - On Friday 23 October, the European Commission approved the proposed acquisition of Schering-Plough by Merck, two US pharmaceutical companies. The overlaps on the asthma and allergic rhinitis markets in the EU were not on a scale that was likely to pose a threat to free competition, the Commission said. However, potential overlaps on the animal health products market led the Commission to require that Merck sell its 50% share in the joint-venture Merial to...